Basher, F., Raez, L., Saravia, D., Rodriguez, E., Uba, R., Arora, A., … De Lima Lopes, G. (2021). Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis. In JOURNAL OF THORACIC ONCOLOGY (Vol. 16, pp. S888–S888).

Basher, F., L. Raez, D. Saravia, E. Rodriguez, R. Uba, A. Arora, J. Ocejo, et al. “Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis.” In JOURNAL OF THORACIC ONCOLOGY, 16:S888–S888, 2021.

Basher F, Raez L, Saravia D, Rodriguez E, Uba R, Arora A, et al. Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis. In: JOURNAL OF THORACIC ONCOLOGY. 2021. p. S888–S888.

Basher, F., et al. “Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis.” JOURNAL OF THORACIC ONCOLOGY, vol. 16, no. 10, 2021, pp. S888–S888.

Basher F, Raez L, Saravia D, Rodriguez E, Uba R, Arora A, Ocejo J, Khan K, Meiyappan K, Dvir K, Fortuna GG, North A, Dumais K, Powery H, Izquierdo P, De Lima Lopes G. Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis. JOURNAL OF THORACIC ONCOLOGY. 2021. p. S888–S888.